Emma Raducanu believed Iga Swiatek when the Pole said that she was “very anxious” after one of her tests came back as doping positive as the Briton admits that players are “quite apprehensive” when it comes to taking supplements because no one wants to unknowingly ingest something prohibited.
As you probably know very well by now, the ITIA announced last Thursday that a sample provided by the world No. 2 in August was positive for trimetazidine (TMZ). In her own statement, the five-time Grand Slam champion said that she was left panicking and absolutely shocked because she had never even heard about the substance before.
Upon an investigation, Swiatek and her team located the culprit – melatonin pills manufactured in Poland were contaminated. Later, the ITIA accepted the 23-year-old’s explanation and her provisional suspension was cut before she was ultimately handed a symbolic one-month ban.
Raducanu, who has been practicing at the National Tennis Centre in London for the past couple of days, spoke with British reporters there. Ahead of the 2025 season, the 2021 US Open champion acknowledged that players deal with anxiety and stress pretty much whenever they have to take something.
Also, the former world No. 10 noted that batch testing something is very expensive. But…
